Suggested Topics within your search.
Suggested Topics within your search.
- Cancer 1
- Gynecology 1
- Obstetrics 1
- Oncology 1
- Pediatric 1
- Pediatric Hematology 1
- Pediatric hematology 1
- methods 1
-
4421
-
4422
Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types
Published 2025-02-01“…Following a prespecified analysis plan, rwOS by TMB level was assessed using Cox PH models adjusted for Eastern Cooperative Oncology Group performance status, prior treatment, microsatellite instability, sex, age, opioid rx pretherapy, and socioeconomic assessment.Results 8440 patients met inclusion criteria. …”
Get full text
Article -
4423
-
4424
-
4425
-
4426
An anoikis-related signature predicts prognosis and immunotherapy response in gastrointestinal cancers
Published 2025-02-01Get full text
Article -
4427
An Optimized NGS Workflow Defines Genetically Based Prognostic Categories for Patients with Uveal Melanoma
Published 2025-01-01Get full text
Article -
4428
-
4429
A video intervention to improve patient understanding of tumor genomic testing in patients with cancer
Published 2024-09-01Get full text
Article -
4430
-
4431
-
4432
-
4433
-
4434
Establishment and practice of the Traditional Chinese Medicine nursing clinic under the mode of Green treatment of tumor (肿瘤中医绿色护理门诊的建立与实践)
Published 2022-01-01“…At the same time, tumor-green nursing technical specifications and standards have been formulated, and a Chinese version of pan-Canadian Oncology Symptom Triage and Remote Support (COSTaRS) Scale has been introduced for the overall, dynamic and comprehensive evaluation of tumor patients. …”
Get full text
Article -
4435
-
4436
Overall Survival of Patients with Metastatic Renal Cell Carcinoma Following the Introduction of Targeted and Immunotherapies: A Norwegian Retrospective, Real-World Registry Data St...
Published 2025-01-01“…Katarina Puco,1 Cathrine S Notland,2 Robert Szulkin,3,4 Christian Jonasson,5 Christian Beisland,6,7 Tom B Johannesen,8 Oddvar Solli,9 Jan Oldenburg,10,11 Daniel Heinrich12 1Department of Oncology, Hematology and Palliative Care, Lovisenberg Diaconal Hospital, Oslo, Norway; 2Department of Medical Affairs, Pfizer AS, Oslo, Norway; 3SDS Life Science, Stockholm, Sweden; 4Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Solna, Sweden; 5Department of Public Health and Nursing, Faculty of Medicine and Health Science, Norwegian University of Science and Technology (NTNU), Trondheim, Norway; 6Department of Urology, Haukeland University Hospital, Bergen, Norway; 7Department of Clinical Medicine, University of Bergen, Bergen, Norway; 8Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway; 9Health and Value, Pfizer AS, Oslo, Norway; 10Department of Oncology, Akershus University Hospital HF, Lørenskog, Norway; 11Faculty of Medicine, University of Oslo, Oslo, Norway; 12Department of Radiotherapy and Oncology, Innlandet Hospital Trust HF, Division Gjøvik/Lillehammer, NorwayCorrespondence: Katarina Puco, Department of Oncology, Hematology and Palliative Care, Lovisenberg Diaconal Hospital, Oslo, Norway, Tel +47 416 86 298, Email katarina.puco@lds.noPurpose: In Norway, 5-year survival rates of patients with renal cell carcinoma (RCC) are increasing. …”
Get full text
Article -
4437
Flow Cytometry Evaluation of Blood-Cell-Bound Surface FVIII in Hemophilia A and Thrombosis
Published 2025-01-01Get full text
Article -
4438
-
4439
Black posterior vitreous detachment: A 10-year historical cohort of pigmented uveal tumors
Published 2025-01-01Get full text
Article -
4440